Luciana Arntson
Adult Health · Henderson, NVNPI 1851316525
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.1% of the total across 424 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 15.9% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 424 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Scilex Pharmaceuticals Inc.$1K
- Collegium Pharmaceutical, Inc.$1K
- AbbVie$1K
- Medtronic$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$951
- Forte Bio-pharma LLC$389
- plus $2K from 24 others
What the payments were for
- Travel & lodging$6068%
- Food & beverage$7,06792%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Scilex Pharmaceuticals Inc. | 93 | $1,220 |
| Collegium Pharmaceutical, Inc. | 89 | $1,137 |
| AbbVie | 60 | $1,121 |
| Medtronic | 18 | $1,003 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 55 | $951 |
| Forte Bio-pharma LLC | 7 | $389 |
| Pfizer | 17 | $285 |
| Redhill Biopharma Inc. | 17 | $272 |
| Protega Pharmaceutials Inc | 12 | $239 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $176 |
| Idorsia Pharmaceuticals US Inc | 6 | $114 |
| IBSA Pharma Inc. | 5 | $101 |
| Axsome Therapeutics, Inc. | 5 | $96 |
| Indivior Inc. | 4 | $90 |
| Lundbeck LLC | 3 | $80 |
| Almatica Pharma LLC | 3 | $75 |
| Arbor Pharmaceuticals, Inc. | 3 | $43 |
| GRT US Holding, Inc. | 2 | $37 |
| Biohaven Pharmaceuticals, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $31 |
| Abbott | 1 | $24 |
| Biodelivery Sciences International, Inc. | 2 | $24 |
| Vertex | 1 | $19 |
| Braeburn Inc. | 1 | $18 |
| Piramal Critical Care | 1 | $17 |
| Orexo US, Inc. | 1 | $16 |
| Amgen | 1 | $16 |
| Biotronik NRO, Inc. | 1 | $15 |
| Novartis | 1 | $14 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$534
- INCEPTIV$153
- QULIPTA$148
- UBRELVY$148
- RELISTOR$116
How this compares
$7,673 in reported general payments places this provider in the 90th percentile of 90 adult health providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 180 | $140,529 |
| RelistorMethylnaltrexone Bromide | 15 | $62,405 |
| ZtlidoLidocaine | 43 | $37,473 |
| Oxycodone Hcl | 1,121 | $36,607 |
| Diclofenac Sodium | 66 | $31,712 |
| Xtampza ErOxycodone Myristate | 44 | $31,705 |
| BelbucaBuprenorphine Hcl | 15 | $18,070 |
| Nucynta ErTapentadol Hcl | 22 | $16,813 |
| Aimovig AutoinjectorErenumab-Aooe | 14 | $14,577 |
| Morphine Sulfate ErMorphine Sulfate | 432 | $14,031 |
| Nurtec OdtRimegepant Sulfate | 14 | $13,797 |
| Oxymorphone Hcl ErOxymorphone Hcl | 19 | $12,295 |
| MovantikNaloxegol Oxalate | 25 | $11,841 |
| Lidocaine | 55 | $8,922 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 233 | $8,857 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta Er | $1,137 | $66,58881 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $951 | $62,40515 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $1,220 | $37,47343 claims |
| PfizerNurtec Odt | $285 | $13,79714 claims |
| Redhill Biopharma Inc.Movantik | $272 | $11,84125 claims |
| AbbVieLinzess | $1,121 | $7,28114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 90 adult health providers in Nevada.
Other adult health in Henderson
- Geraldine DeguzmanHenderson$3K
- Laurie FriedlandHenderson$2K
- Kelly WattersHenderson$585
- Tiffany AlvarezHenderson$429
- Rowena Dela CruzHenderson$428
- Michelle de LunaHenderson$257
- Marcia Castro-RosenbergLas Vegas$64K
- Amanda SquiersLas Vegas$36K
- Jasmina FornbacherLas Vegas$14K
- Marcella PomeranzLas Vegas$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.